EpiPen Competitor Auvi-Q Relauching With Ultimate Copay: $0
Under kaléo's new access program, patients with insurance will have no co-pay and uninsured people with less than $100,000 income will get the product for free.
Under kaléo's new access program, patients with insurance will have no co-pay and uninsured people with less than $100,000 income will get the product for free.